Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
248.88 USD | +0.63% |
|
+4.96% | +8.83% |
Jan. 22 | UBS Adjusts Price Target on ResMed to $255 From $250, Keeps Neutral Rating | MT |
Jan. 19 | SomnoMed Limited Appoints Andrew Price as Director | CI |
Chart calendar ResMed, Inc.
Upcoming events on ResMed, Inc.
Past events on ResMed, Inc.
2025-01-13 06:00 pm | JP Morgan Healthcare Conference |
2024-11-20 07:30 pm | Annual General Meeting |
2024-11-12 06:30 pm | UBS Global Healthcare Conference - Fireside Chat |
2024-11-06 | Détachement de |
2024-10-24 04:30 pm | Q1 2025 Earnings Call |
2024-10-24 04:05 pm | Q1 2025 Earnings Release |
2024-09-30 01:00 pm | Investor Day |
2024-09-04 10:00 am | Morgan Stanley Healthcare Conference - Fireside Chat |
2024-08-14 | Détachement de |
2024-08-01 04:30 pm | Q4 2024 Earnings Call |
2024-08-01 04:05 pm | Q4 2024 Earnings Release |
2024-05-14 04:05 pm | RBC Capital Markets Global Healthcare Conference |
2024-05-07 | Détachement de |
2024-04-25 04:30 pm | Q3 2024 Earnings Call |
2024-04-25 04:05 pm | Q3 2024 Earnings Release |
2024-02-06 | Détachement de |
2024-01-24 04:30 pm | Q2 2024 Earnings Call |
2024-01-24 04:05 pm | Q2 2024 Earnings Release |
2024-01-08 05:15 pm | JPMorgan Healthcare Conference |
2023-11-16 03:00 pm | Annual General Meeting |
Past dividends on ResMed, Inc.
2024-11-06 | Quarterly 0.53 USD |
2024-08-14 | Quarterly 0.53 USD |
2024-05-07 | Quarterly 0.48 USD |
2024-02-06 | Quarterly 0.48 USD |
2023-11-07 | Quarterly 0.48 USD |
2023-08-15 | Quarterly 0.48 USD |
2023-05-09 | Quarterly 0.44 USD |
2023-02-07 | Quarterly 0.44 USD |
2022-11-08 | Quarterly 0.44 USD |
2022-08-16 | Quarterly 0.44 USD |
2022-05-10 | Quarterly 0.42 USD |
2022-02-08 | Quarterly 0.42 USD |
2021-11-08 | Quarterly 0.42 USD |
2021-08-17 | Quarterly 0.42 USD |
2021-05-11 | Quarterly 0.39 USD |
2021-02-09 | Quarterly 0.39 USD |
2020-11-09 | Quarterly 0.39 USD |
2020-08-18 | Quarterly 0.39 USD |
2020-05-12 | Quarterly 0.39 USD |
2020-02-11 | Quarterly 0.39 USD |
Annual results
Fiscal Period | June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 3 578 3 574 0.11% | 4 223 4 235 -0.29% | 4 685 4 678 0.16% | 5 114 | 5 501 | 5 902 |
EBITDA Million USD | Released Forecast Spread | 1 162 1 175 -1.17% | 1 317 1 351 -2.52% | 1 576 1 577 -0.1% | 1 840 | 2 009 | 2 175 |
EBIT Million USD | Released Forecast Spread | 1 000 1 003 -0.26% | 1 224 1 230 -0.47% | 1 478 1 462 1.13% | 1 721 | 1 893 | 2 058 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 960 971 -1.09% | 1 102 1 114 -1.13% | 1 265 1 280 -1.2% | 1 649 | 1 830 | 2 007 |
Net income Million USD | Released Forecast Spread | 779 780 -0.12% | 898 901 -0.42% | 1 021 1 023 -0.23% | 1 328 | 1 476 | 1 622 |
EPS USD | Released Forecast Spread | 5,30 5,29 0.12% | 6,09 6,14 -0.84% | 6,92 6,99 -1.06% | 9,00 | 9,99 | 11,0 |
Announcement Date | 11/08/22 | 03/08/23 | 01/08/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 117 1 051 6.31% | 1 122 1 139 -1.53% | 1 102 1 106 -0.32% | 1 163 1 151 1% | 1 197 1 172 2.12% | 1 223 1 214 0.77% | 1 225 1 183 3.52% | 1 268 | 1 295 | 1 319 | 1 321 | 1 360 | 1 386 | 1 417 |
EBITDA Million USD | Released Forecast Spread | 345 335 3.06% | 333 357 -6.68% | 364 341 6.69% | 390 362 7.98% | 418 392 6.74% | 425 426 -0.26% | 451 413 9.21% | 462 | 474 | 485 | 488 | 509 | 516 | 527 |
EBIT Million USD | Released Forecast Spread | 321 313 2.78% | 307 325 -5.52% | 319 309 3.12% | 366 342 6.93% | 394 362 8.67% | 400 392 2.24% | 406 383 6.08% | 430 | 442 | 448 | 454 | 470 | 480 | 488 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 289 263 10.03% | 277 289 -4.35% | 272 276 -1.54% | 259 316 -17.88% | 375 327 14.72% | 358 358 -0.2% | 383 364 5.33% | 409 | 422 | 440 | 434 | 449 | 462 | 479 |
Net income Million USD | Released Forecast Spread | 233 216 7.86% | 230 233 -1.34% | 219 220 -0.38% | 209 245 -14.76% | 300 266 13.08% | 292 296 -1.13% | 311 292 6.65% | 329 | 339 | 350 | 345 | 359 | 366 | 375 |
EPS USD | Released Forecast Spread | 1,58 1,47 7.14% | 1,56 1,58 -0.98% | 1,49 1,47 1.13% | 1,42 1,64 -13.54% | 2,04 1,77 14.97% | 1,98 2,00 -0.76% | 2,11 1,95 7.97% | 2,23 | 2,32 | 2,38 | 2,37 | 2,50 | 2,56 | 2,60 |
Announcement Date | 27/04/23 | 03/08/23 | 26/10/23 | 24/01/24 | 25/04/24 | 01/08/24 | 24/10/24 | - | - | - | - | - | - | - |
2025-01-28 | REVVITY, INC.: Q4 2024 Earnings Release (Projected) |
2025-01-29 06:00 am | DANAHER CORPORATION: Q4 2024 Earnings Release |
2025-01-30 06:00 am | THERMO FISHER SCIENTIFIC INC.: Q4 2024 Earnings Release |
2025-01-30 04:05 pm | RESMED, INC.: Q2 2025 Earnings Release |
2025-01-30 | FUKUDA DENSHI CO., LTD.: Q3 2024 Earnings Release |
2025-02-03 | INMODE LTD.: Q4 2024 Earnings Release |
2025-02-04 | NIHON KOHDEN CORPORATION: Q3 2024 Earnings Release |
2025-02-05 06:30 am | BOSTON SCIENTIFIC CORPORATION: Q4 2024 Earnings Release |
2025-02-05 04:01 pm | HOLOGIC, INC.: Q1 2025 Earnings Release |
2025-02-06 01:00 am | SIEMENS HEALTHINEERS AG: Q1 2025 Earnings Release |
Past sector events for ResMed, Inc.
2025-01-23 04:05 pm | INTUITIVE SURGICAL, INC.: Q4 2024 Earnings Release |
2025-01-22 04:35 pm | NANOSONICS LIMITED: Q2 2025 Sales and Revenue Release - Trading Update |
2025-01-13 02:00 am | OXFORD NANOPORE TECHNOLOGIES PLC: Q4 2024 Sales and Revenue Release - Trading Update |
2024-12-11 01:00 am | CARL ZEISS MEDITEC AG: Q4 2024 Earnings Release |
2024-11-27 01:30 am | ELEKTA AB: Q2 2025 Earnings Release |
2024-11-25 04:05 pm | AGILENT TECHNOLOGIES, INC.: Q4 2024 Earnings Release |
2024-11-07 | OLYMPUS CORPORATION: Q2 2025 Earnings Release |
2024-11-07 07:00 am | AXOGEN, INC.: Q3 2024 Earnings Release |
2024-11-06 | CLASSYS INC.: Q3 2024 Earnings Release |
2024-11-06 | NIHON KOHDEN CORPORATION: Q2 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RMD Stock
- Calendar ResMed, Inc.